Adaptive zone model predictive control with a glucose and velocity dependent dynamic cost function for an artificial pancreas
US-12128212-B2 · Oct 29, 2024 · US
US11213622B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11213622-B2 |
| Application number | US-201916560497-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 4, 2019 |
| Priority date | May 22, 2009 |
| Publication date | Jan 4, 2022 |
| Grant date | Jan 4, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.
Opening claim text (preview).
What is claimed is: 1. A method comprising: detecting an analyte level of a user using an analyte sensor; and delaying an annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein an amount of the delay is based on a duration of time in which the analyte level has not exceeded the analyte threshold. 2. The method of claim 1 , wherein the analyte threshold is a low analyte threshold. 3. The method of claim 1 , wherein the analyte level is a glucose level. 4. The method of claim 3 , wherein the analyte level is an interstitial glucose level. 5. The method of claim 1 , further comprising sounding an alarm after the delay. 6. The method of claim 5 , wherein sounding the alarm after the delay is performed by an electronic device in communication with the analyte sensor. 7. The method of claim 6 , wherein the electronic device comprises a display for user input and output communication. 8. The method of claim 1 , wherein the electronic device is further configured to recommend medication based on the analyte level. 9. The method of claim 1 , wherein the duration of time corresponds to a duration the analyte level was in a euglycemic range prior to exceeding the analyte threshold. 10. An analyte monitoring system comprising: an analyte sensor configured for detecting an analyte level of a user; a processor operably coupled to the analyte sensor; and a memory operably coupled to the processor, wherein the memory includes instructions stored therein that, when executed by the processor, cause the processor to: detect the analyte level using the analyte sensor; and delay an annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein an amount of the delay is based on a duration of time in which the analyte level has not exceeded the analyte threshold. 11. The system of claim 10 , wherein the analyte threshold is a low analyte threshold. 12. The system of claim 10 , wherein the analyte level is a glucose level. 13. The system of claim 12 , wherein the analyte level is an interstitial glucose level. 14. The system of claim 10 , further comprising sounding an alarm after the delay. 15. The system of claim 14 , wherein the electronic device comprises a display for user input and output communication. 16. The system of claim 14 , wherein the electronic device is further configured to recommend medication based on the analyte level. 17. The system of claim 14 , wherein the electronic device is further in communication with a medication delivery device. 18. The system of claim 10 , wherein the duration of time corresponds to a duration the analyte level was in a euglycemic range prior to exceeding the analyte threshold.
using feedback of body parameters, e.g. blood-sugar, pressure (measurement of body parameters A61B5/00) · CPC title
worn on the body to detect health condition by physiological monitoring, e.g. electrocardiogram, temperature, breathing (detecting, measuring or recording for diagnostic purposes A61B5/00) · CPC title
Pressure infusion, e.g. using pumps · CPC title
for remote operation · CPC title
Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.